vs
Hess Midstream LP（HESM）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
Orthofix Medical Inc.的季度营收约是Hess Midstream LP的1.1倍（$219.9M vs $204.1M），Hess Midstream LP净利率更高（77.3% vs -1.0%，领先78.3%），Hess Midstream LP同比增速更快（2.1% vs 2.0%），过去两年Orthofix Medical Inc.的营收复合增速更高（8.0% vs -25.3%）
赫斯是美国全球化独立能源企业，主要从事原油与天然气的勘探、生产业务。公司于1968年由赫斯石油化工和阿美拉达石油合并成立，2023年10月同意被雪佛龙收购，相关交易已于2025年7月完成交割。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
HESM vs OFIX — 直观对比
营收规模更大
OFIX
是对方的1.1倍
$204.1M
营收增速更快
HESM
高出0.1%
2.0%
净利率更高
HESM
高出78.3%
-1.0%
两年增速更快
OFIX
近两年复合增速
-25.3%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $204.1M | $219.9M |
| 净利润 | $157.7M | $-2.2M |
| 毛利率 | — | 71.1% |
| 营业利润率 | 116.7% | 0.2% |
| 净利率 | 77.3% | -1.0% |
| 营收同比 | 2.1% | 2.0% |
| 净利润同比 | -2.3% | 92.4% |
| 每股收益（稀释后） | $0.68 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HESMOFIX
| Q1 26 | $204.1M | — | ||
| Q4 25 | $404.2M | $219.9M | ||
| Q3 25 | $420.9M | $205.6M | ||
| Q2 25 | $414.2M | $203.1M | ||
| Q1 25 | $382.0M | $193.6M | ||
| Q4 24 | $395.9M | $215.7M | ||
| Q3 24 | $378.5M | $196.6M | ||
| Q2 24 | $365.5M | $198.6M |
净利润HESMOFIX
| Q1 26 | $157.7M | — | ||
| Q4 25 | $93.3M | $-2.2M | ||
| Q3 25 | $97.7M | $-22.8M | ||
| Q2 25 | $90.3M | $-14.1M | ||
| Q1 25 | $71.6M | $-53.1M | ||
| Q4 24 | $70.4M | $-29.1M | ||
| Q3 24 | $58.6M | $-27.4M | ||
| Q2 24 | $49.5M | $-33.4M |
毛利率HESMOFIX
| Q1 26 | — | — | ||
| Q4 25 | — | 71.1% | ||
| Q3 25 | — | 72.2% | ||
| Q2 25 | — | 68.7% | ||
| Q1 25 | — | 62.8% | ||
| Q4 24 | — | 69.0% | ||
| Q3 24 | — | 68.7% | ||
| Q2 24 | — | 67.8% |
营业利润率HESMOFIX
| Q1 26 | 116.7% | — | ||
| Q4 25 | 62.2% | 0.2% | ||
| Q3 25 | 61.5% | -8.3% | ||
| Q2 25 | 62.8% | -7.9% | ||
| Q1 25 | 62.1% | -25.2% | ||
| Q4 24 | 61.4% | -5.3% | ||
| Q3 24 | 61.2% | -9.6% | ||
| Q2 24 | 60.8% | -12.5% |
净利率HESMOFIX
| Q1 26 | 77.3% | — | ||
| Q4 25 | 23.1% | -1.0% | ||
| Q3 25 | 23.2% | -11.1% | ||
| Q2 25 | 21.8% | -6.9% | ||
| Q1 25 | 18.7% | -27.4% | ||
| Q4 24 | 17.8% | -13.5% | ||
| Q3 24 | 15.5% | -13.9% | ||
| Q2 24 | 13.5% | -16.8% |
每股收益（稀释后）HESMOFIX
| Q1 26 | $0.68 | — | ||
| Q4 25 | — | $-0.05 | ||
| Q3 25 | — | $-0.57 | ||
| Q2 25 | — | $-0.36 | ||
| Q1 25 | — | $-1.35 | ||
| Q4 24 | — | $-0.76 | ||
| Q3 24 | — | $-0.71 | ||
| Q2 24 | — | $-0.88 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $82.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | — | $450.0M |
| 总资产 | — | $850.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资HESMOFIX
| Q1 26 | — | — | ||
| Q4 25 | $1.9M | $82.0M | ||
| Q3 25 | $5.5M | $62.9M | ||
| Q2 25 | $4.5M | $65.6M | ||
| Q1 25 | $6.1M | $58.0M | ||
| Q4 24 | $4.3M | $83.2M | ||
| Q3 24 | $10.3M | $30.1M | ||
| Q2 24 | $99.6M | $26.4M |
总债务HESMOFIX
| Q1 26 | — | — | ||
| Q4 25 | $3.8B | — | ||
| Q3 25 | — | $157.2M | ||
| Q2 25 | — | $157.0M | ||
| Q1 25 | — | $156.9M | ||
| Q4 24 | $3.5B | $157.0M | ||
| Q3 24 | — | $118.5M | ||
| Q2 24 | — | $118.0M |
股东权益HESMOFIX
| Q1 26 | — | — | ||
| Q4 25 | — | $450.0M | ||
| Q3 25 | — | $442.5M | ||
| Q2 25 | — | $458.3M | ||
| Q1 25 | — | $458.3M | ||
| Q4 24 | — | $503.1M | ||
| Q3 24 | — | $525.9M | ||
| Q2 24 | — | $546.0M |
总资产HESMOFIX
| Q1 26 | — | — | ||
| Q4 25 | $4.4B | $850.6M | ||
| Q3 25 | $4.4B | $832.6M | ||
| Q2 25 | $4.4B | $837.2M | ||
| Q1 25 | $4.3B | $823.1M | ||
| Q4 24 | $4.2B | $893.3M | ||
| Q3 24 | $4.1B | $867.9M | ||
| Q2 24 | $4.1B | $882.0M |
负债/权益比HESMOFIX
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 0.36× | ||
| Q2 25 | — | 0.34× | ||
| Q1 25 | — | 0.34× | ||
| Q4 24 | — | 0.31× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.22× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $253.3M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | — | $16.8M |
| 自由现金流率自由现金流/营收 | — | 7.6% |
| 资本支出强度资本支出/营收 | 51.4% | 4.9% |
| 现金转化率经营现金流/净利润 | 1.61× | — |
| 过去12个月自由现金流最近4个季度 | — | $-1.3M |
8季度趋势，按日历期对齐
经营现金流HESMOFIX
| Q1 26 | $253.3M | — | ||
| Q4 25 | $245.6M | $27.7M | ||
| Q3 25 | $258.9M | $12.4M | ||
| Q2 25 | $276.9M | $11.6M | ||
| Q1 25 | $202.4M | $-18.4M | ||
| Q4 24 | $258.5M | $23.7M | ||
| Q3 24 | $224.9M | $11.7M | ||
| Q2 24 | $271.6M | $9.0M |
自由现金流HESMOFIX
| Q1 26 | — | — | ||
| Q4 25 | $178.9M | $16.8M | ||
| Q3 25 | $178.9M | $2.5M | ||
| Q2 25 | $213.5M | $4.5M | ||
| Q1 25 | $156.9M | $-25.1M | ||
| Q4 24 | $163.4M | $15.2M | ||
| Q3 24 | $132.6M | $6.3M | ||
| Q2 24 | $207.7M | $-360.0K |
自由现金流率HESMOFIX
| Q1 26 | — | — | ||
| Q4 25 | 44.3% | 7.6% | ||
| Q3 25 | 42.5% | 1.2% | ||
| Q2 25 | 51.5% | 2.2% | ||
| Q1 25 | 41.1% | -13.0% | ||
| Q4 24 | 41.3% | 7.0% | ||
| Q3 24 | 35.0% | 3.2% | ||
| Q2 24 | 56.8% | -0.2% |
资本支出强度HESMOFIX
| Q1 26 | 51.4% | — | ||
| Q4 25 | 16.5% | 4.9% | ||
| Q3 25 | 19.0% | 4.8% | ||
| Q2 25 | 15.3% | 3.5% | ||
| Q1 25 | 11.9% | 3.5% | ||
| Q4 24 | 24.0% | 4.0% | ||
| Q3 24 | 24.4% | 2.7% | ||
| Q2 24 | 17.5% | 4.7% |
现金转化率HESMOFIX
| Q1 26 | 1.61× | — | ||
| Q4 25 | 2.63× | — | ||
| Q3 25 | 2.65× | — | ||
| Q2 25 | 3.07× | — | ||
| Q1 25 | 2.83× | — | ||
| Q4 24 | 3.67× | — | ||
| Q3 24 | 3.84× | — | ||
| Q2 24 | 5.49× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HESM
| Affiliate services | $197.9M | 97% |
| Third-party services | $6.2M | 3% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
